UBLCP1
Ubiquitin-like domain-containing CTD phosphatase 1
Also known as: CPUB1, MGC10067, UBCP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WVY7
- Gene
- UBLCP1
- Ensembl
- ENSG00000164332
- Chromosome
- 5
- Canonical length
- 318 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nucleoli rim
OverviewNCBI Gene
Enables proteasome regulatory particle binding activity and protein serine/threonine phosphatase activity. Involved in negative regulation of ATP-dependent activity and regulation of proteasome assembly. Located in nucleolus and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
318 residues, UniProt reviewed canonical sequence.
>Q8WVY7|UBLCP1
1 MALPIIVKWG GQEYSVTTLS EDDTVLDLKQ FLKTLTGVLP ERQKLLGLKV KGKPAENDVK
61 LGALKLKPNT KIMMMGTREE SLEDVLGPPP DNDDVVNDFD IEDEVVEVEN REENLLKISR
121 RVKEYKVEIL NPPREGKKLL VLDVDYTLFD HRSCAETGVE LMRPYLHEFL TSAYEDYDIV
181 IWSATNMKWI EAKMKELGVS TNANYKITFM LDSAAMITVH TPRRGLIDVK PLGVIWGKFS
241 EFYSKKNTIM FDDIGRNFLM NPQNGLKIRP FMKAHLNRDK DKELLKLTQY LKEIAKLDDF
301 LDLNHKYWER YLSKKQGQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBLCP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 35 nTPM
- thymus: 34 nTPM
- lymph node: 32 nTPM
- testis: 29 nTPM
- cerebral cortex: 27 nTPM
- spleen: 25 nTPM
Single-cell type
- neutrophils: 149 nCPM
- breast lactating cells: 109 nCPM
- neutrophil progenitors: 92 nCPM
- early primary spermatocytes: 83 nCPM
- esophageal apical cells: 76 nCPM
- undifferentiated spermatogonia: 64 nCPM
Immune cell
- basophil: 48 nTPM
- NK-cell: 43 nTPM
- neutrophil: 31 nTPM
- naive CD8 T-cell: 29 nTPM
- MAIT T-cell: 28 nTPM
- T-reg: 28 nTPM
Brain region
- cerebral cortex: 29 nTPM
- thalamus: 26 nTPM
- hypothalamus: 25 nTPM
- white matter: 25 nTPM
- pons: 25 nTPM
- medulla oblongata: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 2.06
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of ATP-dependent activity
- regulation of proteasome assembly
Molecular functions
- metal ion binding
- proteasome regulatory particle binding
- protein serine/threonine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin-like domain
- FCP1 homology domain
- HAD superfamily
- Ubiquitin-like domain superfamily
- HAD-like superfamily
- Ubiquitin family
- NLI interacting factor-like phosphatase
- HAD-superfamily hydrolase, subfamily IIID
- Ubiquitin-like domain-containing CTD phosphatase 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBLCP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBLCP1 as an antibody target. Whether an autoantibody or antibody against UBLCP1 could matter depends on whether native UBLCP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBLCP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBLCP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...